INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

Go back to INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
(NASDAQ: INMB) Delayed: 1.62 -0.1 (5.81%)
Previous Close $1.72    52 Week High
Open $1.69    52 Week Low
Day High $1.71    P/E N/A 
Day Low $1.61    EPS
Volume 186,095       

(NASDAQ: INMB) Delayed: 1.62 -0.1 (5.81%)
Previous Close $1.72    52 Week High
Open $1.69    52 Week Low
Day High $1.71    P/E N/A 
Day Low $1.61    EPS
Volume 186,095